84
Views
31
CrossRef citations to date
0
Altmetric
Research Article

Effects of the Correction of Renal Artery Stenosis on Blood Pressure, Renal Function and Left Ventricular Morphology

Pages 141-150 | Published online: 08 Jul 2009

References

  • Davis, BA Crook, JE Vestal, RE Oates, JA. Prevalence of renovascular hypertension in patients with grade III or IV hypertensive retinopathy. N Engl J Med 1979; 301: 1273–6.
  • Scoble, J Mahler, ER Hamilton, G Dick, R Sweny, P Moorhead, JF. Atherosclerotic renovascular disease causing renal failure-a case for treatment. Clin Nephrol 1989; 31: 119–22.
  • Mailloux, LU Belluci, AG Mossey, RT, et al. Predictors of survival in patients undergoing dialysis. Am J Med 1988; 84: 855–62.
  • Appel, RG Bleyer, AJ Reavis, S Hansen, KJ. Renovascular disease in older patients beginning renal replacement therapy. Kidney Int 1995; 48: 171–6.
  • Simon, N Franklin, SS Bleifer, KH Maxwell, MH. Clinical characteristics of renovascular hypertension. JAMA 1972; 220: 1209–18.
  • Vensel, LA Devereux, RB Pickering, TG Herrold, EM Borer, JS Laragh, JH. Cardiac structure and function in renovascular hypertension produced by unilateral and bilateral renal artery stenosis. Am J Cardiol 1986; 58: 575–82.
  • Losito, A Fagugli, RM Zampi, I, et al. Comparison of target organ damage in renovascular and essential hypertension. Am J Hypertens 1996; 9: 1062–7.
  • Dean, RH Lawson, JD Hollifield, JVV Shack, RB Polterauer, P Rhamy, RK. Revascularization of the poorly functioning kidney. Surgery 1979; 85: 44–52.
  • Ying, CY Tifft, CP Gavras, H Chobanian, AV. Renal revascularization in the azotemic hypertensive patient resistant to therapy. N Engl J Med 1984; 311: 1070–5.
  • Rimmer, JM Gennari, FJ. Atherosclerotic renovascular disease and progressive renal failure. Ann Intern Med 1993; 118: 712–9.
  • Gruntzig, A Kuhlmann, U Vetter, W Lutolf, U Meier, B Siegenthaler, W. Treatment of renovascular hypertension with percutaneous transluminal dilatation of a renal-artery stenosis. Lancet 1978; 1: 801–2.
  • Bonelli, FS McKusick, MA Textor, SC, et al. Renal artery angioplasty: technical results and clinical outcome in 320 patients. Mayo Chin Proc 1995; 70: 1041–52.
  • Ramsay, LE Waller, PC. Blood pressure response to percutaneous transluminal angioplasty for renovascular hypertension: an overview of published series. Br Med J 1990; 300: 569–72.
  • Jensen, G Zachrisson, BF Delin, K Volkmann, R Aurell, M. Treatment of renovascular hypertension: one year results of renal angioplasty. Kidney Int 1995; 48: 1936–45.
  • Klinge, J Mali, WP Puijlaert, CB Geyskes, GG Becking, WB Feldberg, MA. Percutaneous transluminal renal angioplasty: initial and long-term results. Radiology 1989; 171: 501–6.
  • Plouin, PF Dame, B Chatellier, G, et al. Restenosis after a first percutaneous transluminal renal angioplasty. Hyperten-sion 1993; 21: 89–96.
  • Plouin, PF Chatellier, G Dame, B Raynaud, A. Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis. Hypertension 1998; 31: 823–9.
  • Novick, AC Ziegelbaum, M Vidt, DG Gifford, RW, Jr. Pohl, MA Goormastic, M. Trends in surgical revasculariza-tion for renal artery disease. Ten years' experience. JAMA 1987; 257: 498–501.
  • Sos, TA Pickering, TG Sniderman, K, et al. Percutaneous transluminal renal angioplasty in renovascular hypertension BLOOD PRESSURE 1999 due to atheroma or fibromuscular dysplasia. N Engl J Med 1983; 309: 274–9.
  • Kuhlmann, U Greminger, P Gruntzig, A, et al. Long-term experience in percutaneous transluminal dilatation of renal artery stenosis. Am J Med 1985; 79: 692–8.
  • Tanaka, T Natsume, T Shibata, H, et al. Circadian rhythm of blood pressure in primary aldosteronism and renovas- cular hypertensionanalysis by the cosinor method. JpnCirc J 1983; 47: 788–94.
  • Baumgart, P Walger, P Dorst, KG von Eiff, M Rahn, KH Vetter, H. Can secondary hypertension be identified by twenty-four- hour ambulatory pressure monitoring? J Hypertens 1989; (Suppl 7): S25–8.
  • Gosse, P Jullien, E Reynaud, P Dallocchio, M. Circadian rhythm of blood pressure. Importance of the severity and not the cause of arterial hypertension. Arch Mal Coeur Vas 1988; 81 Spec No: 247–50.
  • Padfield, PL Stewart, MJ. Ambulatory blood pressure monitoring in secondary hypertension. J Hypertens Suppl 1991; 9: S69–71.
  • Ravogli, A Arzilli, F Omboni, S, et al. Lack of effect of percutaneous transluminal renal angioplasty on nocturnal hypotension in renovascular hypertensive patients. J Hypertens 1996: 14.
  • Bianchi, S Bigazzi, R Valtriani, C, et al. Elevated serum lipoprotein (a) in patients with essential hypertension and microalbuminuria. Am J Hypertens 1993; 6: 46A.
  • Pattynama, PM Becker, GJ Brown, J Zemel, G Benenati, JF Katzen, BT. Percutaneous angioplasty for atherosclerotic renal artery disease: effect on renal function in azotemic patients. Cardiovasc Intervent Radiol 1994; 17: 143–6.
  • Kumar, A Shapiro, AP. Proteinuria and nephrotic syndrome induced by renin in patients with renal artery stenosis. Arch Intern Med 1980; 140: 1631–4.
  • Zimbler, MS Pickering, TG Sos, TA Laragh, JH. Proteinur-ia in renovascular hypertension and the effects of renal angioplasty. Am J Cardiol 1987; 59: 406–8.
  • Montoliu, J Botey, A Torras, A Darnell, A Revert, L. Renin-induced massive proteinuria in man. Clin Nephrol 1979; 11: 267–71.
  • Mimran, A Rib stein, J DuCailar, G. Is microalbuminuria a marker of early intrarenal vascular dysfunction in essential hypertension? Hypertension 1994; 23: 1018–21.
  • Bianchi, S Bigazzi, R Baldari, G Campese, VM. Micro-albuminuria in patients with essential hypertension: effects of several antihypertensive drugs. Am J Med 1992; 93: 525–8.
  • Alli, C Lombardo, M Zanni, D Agrati, AM Cassani, M Granata, S. Albuminuria and transferinuria in essential hypertension. Effects of antihypertensive therapy. J Hyper-tens 1996; 9: 1068–76.
  • Damsgaard, EM Froland, A Jorgensen, OD Mongensen, CE. Microalbuminuria as a predictor of increased mortality in elderly people. Br Med J 1990; 300: 297–300.
  • Yudkin, JS Forrest, RD Jackson, CA. Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Lancet 1988; 2: 530–3.
  • Cerasola, G Cottone, S Mule, G, et al. Microalbuminuria, renal dysfunction and cardiovascular complication in essential hypertension. J Hypertens 1996; 14: 915–20.
  • Bigazzi, R Bianchi, S Campese, VM Baldari, G. Prevalence of microalbuminuria in a large population of patients with mild to moderate essential hypertension. Nephron 1992; 61: 94–7.
  • Khairllah, PA Kanabus, J. Cardiac hypertrophy in hyper-tension. In: Tarazi RC, Dunbar JB, editors. Angiotensin and myocardial protein synthesis. New York: Raven Press Publishers, 1983: 337–47.
  • Yoshitomi, Y Nishikimi, T Abe, H, et al. Comparison of changes in cardiac structure after treatment in secondary hypertension. Hypertension 1996; 27: 319–23.
  • Hoffmann, U Edwards, JM Carter, S, et al. Role of duplex scanning for the detection of atherosclerotic renal artery disease. Kidney Int 1991; 39: 1232–9.
  • Taylor, DC Kettler, MD Moneta, GL, et al. Duplex ultrasound scanning in the diagnosis of renal artery stenosis: a prospective evaluation. J Vase Surg 1988; 7: 363–9.
  • Baumgartner, I Triller, J Mahler, F. Patency of percuta-neous transluminal renal angioplasty: a prospective sono-graphic study. Kidney Int 1997; 51: 798–803.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.